Flag of the European Union EU Clinical Trials Register Help

Clinical trials for KERATOSIS

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44349   clinical trials with a EudraCT protocol, of which   7376   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    127 result(s) found for: KERATOSIS. Displaying page 6 of 7.
    « Previous 1  2  3  4  5  6  7  Next»
    EudraCT Number: 2004-002761-21 Sponsor Protocol Number: ADO-Solaraze-AK-3-6 Start Date*: 2005-08-08
    Sponsor Name:University Medical Center
    Full Title: RANDOMIZED, MULTICENTRE OPEN LABEL STUDY TO COMPARE THE EFFICACY AND TOLERABILITY OF SOLARAZE® FOR 3 MONTHS VERSUS 6 MONTHS IN PATIENTS WITH MILD TO MODERATE ACTINIC KERATOSIS LOCATED AT THE FACE A...
    Medical condition: Mild to moderate actinic keratoses located at the face and head
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-005984-25 Sponsor Protocol Number: 28-11-2011version1 Start Date*: 2012-02-15
    Sponsor Name:Bispebjerg Hospital
    Full Title: Inflammation after photodynamic therapy of actinic keratoses
    Medical condition: Actinic keratoses
    Disease: Version SOC Term Classification Code Term Level
    14.1 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2017-000066-29 Sponsor Protocol Number: RD.03.SPR.114384 Start Date*: 2017-05-15
    Sponsor Name:Galderma R&D
    Full Title: Subject reported outcomes on satisfaction, efficacy and safety with Luxerm® in the field-directed treatment of thin or non-hyperkeratotic and non-pigmented Actinic Keratosis of the face or the scalp
    Medical condition: Thin or non-hyperkeratotic and non-pigmented Actinic Keratosis on the face and scalp
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10020648 Hyperkeratoses HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-002632-15 Sponsor Protocol Number: BAK-08 Start Date*: 2008-10-10
    Sponsor Name:Birken GmbH
    Full Title: Randomized, multicenter, double blind study to compare the efficacy and tolerability of Oleogel-S-10 for 3 months versus placebo only in patients with mild to moderate ac-tinic keratoses located at...
    Medical condition: Die Studie ist eine randomisierte, multizentrische, doppelt verblindete Studie zum Vergleich der Wirksamkeit und Verträglichkeit einer Behandlung mit Oleogel-S-10 über 3 Monate vs. Placebo bei Pati...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-002663-42 Sponsor Protocol Number: TFDTRASP Start Date*: 2015-11-13
    Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra
    Full Title: RANDOMISED PILOT STUDY TO ASSESS THE CLINICAL EFFICACY OF DAYLIGHT PHOTODYNAMIC THERAPY WITH METHYL AMINOLEVULINATE CREAM (METVIX?), (MAL-PDT), IN THE PREVENTION OF ACTINIC KERATOSIS AND NON MELANO...
    Medical condition: Actinic Keratosis (AK) are histologically characterized by the proliferation of keratinocytes with atypical cytology in the epidermis. One of the main risk factors for its occurrence is immunosuppr...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2015-003804-21 Sponsor Protocol Number: DFD-07-CD-001 Start Date*: 2015-11-12
    Sponsor Name:Promius Pharma LLC
    Full Title: Multi-centre, Randomized, Double-blind, Placebo-Controlled Pilot Safety and Efficacy Study of 8 Weeks of Treatment with DFD-07 for Actinic Keratosis of the Face and Scalp
    Medical condition: Actinic Keratosis (AK)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-004403-13 Sponsor Protocol Number: PDT002/12 Start Date*: 2013-08-27
    Sponsor Name:Medizinische Universität Wien, Univ. Klinik für Dermatologie
    Full Title: Placebo-controlled cross-over study on the efficacy of a non-steroidal antirheumatic drug for pain reduction during photodynamic therapy of actinic keratoses
    Medical condition: actinic keratosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004753-95 Sponsor Protocol Number: DBTY 000/Capsulin/1Mar Start Date*: 2006-03-27
    Sponsor Name:Diabetology Ltd
    Full Title: A Phase II, Dose Ranging Single Centre, Single Blind, Parallel-group, Controlled Study of the Safety, Tolerability and Effects on Metabolic Control of an Oral Insulin Formulation in a Type II Diabe...
    Medical condition: Type II Diabetes
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004258-26 Sponsor Protocol Number: 02_2004 Start Date*: 2005-06-23
    Sponsor Name:University Clinic of Dermatology Division of Special and Enviromental Dermatology
    Full Title: Photodynamic Therapy (PDT) vs Chemopeeling for the treatment of multiple actinic keratoses on the underarms
    Medical condition: Actinic Keratosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2010-019788-12 Sponsor Protocol Number: ICT2010/BEL/1/PLcr Start Date*: 2010-08-13
    Sponsor Name:Laboratoire BIODERMA
    Full Title: Evaluation de la tolérance d'un produit cosmétique dans les suites de séances de photothérapie dynamique
    Medical condition: The subjects who will participate in the clinical study will have actinic keratoses and/or superficial basal cell carcinoma that need to be treated by dynamic phototherapy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003934-40 Sponsor Protocol Number: Help Pharmaceuticals SA Start Date*: 2008-03-20
    Sponsor Name:HELP Pharmaceuticals SA
    Full Title: A multicenter, randomised, double-blind, placebo-controlled, parallel groups clinical trial for the evaluation of efficacy and safety of diclofenac sodium 3% administered topically in patients with...
    Medical condition: patients with actinic keratoses (AK)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014833-26 Sponsor Protocol Number: IEO S500/409 Start Date*: 2010-07-29
    Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA
    Full Title: Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions. An Inter-Consortium Collaborative Study.
    Medical condition: oral premalignant lesions
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024396 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-000545-39 Sponsor Protocol Number: DERMAQ-001 Start Date*: 2018-04-30
    Sponsor Name:ASL 1 AVEZZANO-SULMONA-L'AQUILA
    Full Title: A randomized half-side comparative study of Methyl aminolevulinate (MAL, Metvix®) Daylight photodynamic therapy (DL-PDT) with or without pre-treatment with calcitriol (Silkis®) for Actinic Keratosi...
    Medical condition: Actinic Keratosis
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004858 10020648 Hyperkeratoses HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-003895-15 Sponsor Protocol Number: 82720 Start Date*: 2022-02-23
    Sponsor Name:Bispebjerg Hospital, Department of Dermatology and Venereology
    Full Title: Impact of human papillomavirus (HPV) vaccination on burden of disease in patients with actinic keratosis ― a double-blind randomized controlled trial
    Medical condition: Actinic Keratosis (AK)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10052567 Skin preneoplastic conditions NEC HLT
    20.0 100000004858 10040901 Skin neoplasms malignant and unspecified (excl melanoma) HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-003917-17 Sponsor Protocol Number: BAK04 Start Date*: 2005-03-07
    Sponsor Name:Birken GmbH
    Full Title: Treatment of actinic keratoses with Birken-Oleogel in comparison to cryotherapy and the combination of cryotherapy plus Birken-Oleogel: a randomized, monocenter study. Behandlung aktinischer Kerat...
    Medical condition: Actinic keratoses. These are dysplasia of the epidermis caused by chronic UV-irradiation, that developwithout treatment in 20% of the cases into skin cancer (spinalioma). aktinische Keratosen. Die...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005121-13 Sponsor Protocol Number: Daylight_01 Start Date*: 2015-07-22
    Sponsor Name:University Hospital Regensburg
    Full Title: Prospective, randomized, controlled, multicenter, two-armed, study comparing daylight photodynamic therapy using MAL with cryosurgery for the treatment and prophylaxis of actinic keratoses in photo...
    Medical condition: Actinic keratoses and photoaged skin
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-005015-13 Sponsor Protocol Number: PC T405/05 Start Date*: 2006-02-16
    Sponsor Name:PhotoCure ASA
    Full Title: A multicenter, double blind, vehicle-controlled, randomized study of photodynamic therapy (PDT) with Metvix®160 mg/g cream and Aktilite CL128 LED light in patients with multiple actinic keratoses o...
    Medical condition: actinic keratosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2022-003326-44 Sponsor Protocol Number: TIRBA-2022-02 Start Date*: 2023-04-11
    Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Dermatologie und Venerologie
    Full Title: SunDamage: Tirbanibulin 1% Ointment for the treatment of chronically sun-damaged skin on the face
    Medical condition: Subclinical lesions in UV-exposed areas of chronically UV-damaged skin in the face adjacent to lesions caused by actinic keratosis but not obviously affected themselves.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2013-000973-54 Sponsor Protocol Number: RD.03.SPR.29112 Start Date*: 2013-06-04
    Sponsor Name:Galderma R&D SNC
    Full Title: Multi-centre, randomized, investigator-blind, intra-individual active and vehicle-controlled study, comparing Metvix® Natural Daylight Photodynamic Therapy versus Metvix® conventional Photodynamic ...
    Medical condition: Mild and/or moderate Actinic Keratoses
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004858 10020648 Hyperkeratoses HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) NL (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2018-000189-12 Sponsor Protocol Number: LS2018 Start Date*: 2018-03-23
    Sponsor Name:Bispebjerg Hospital
    Full Title: Treatment of photodamaged skin of the décolleté with fractional laser, radio-frequency microneedling, and photodynamic therapy
    Medical condition: Photodamaged skin in the décolleté
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10065944 Photodamaged skin LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Jul 16 10:58:47 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA